Advanced search
Publication Cover
Future Oncology Latest Articles
Submit an article Journal homepage
657
Views
0
CrossRef citations to date
0
Altmetric
Clinical Trial Protocol

LEAP-014: first-line lenvatinib + pembrolizumab + chemotherapy in advanced/metastatic esophageal squamous cell carcinoma

Jong-Mu Sun1 Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of KoreaCorrespondence[email protected]
View further author information
,
Antoine Adenis2 Institut du Cancer de Montpellier & IRCM, Université Montpellier, Montpellier, FranceView further author information
,
Peter C Enzinger3 Dana-Farber Cancer Institute, Boston, MA, USAView further author information
,
Manish A Shah4 Weill Cornell Medical College, New York-Presbyterian Hospital, New York, NY, USAORCID Iconhttps://orcid.org/0000-0002-6913-9655View further author information
ORCID Icon,
Ken Kato5 National Cancer Center Hospital, Tokyo, JapanORCID Iconhttps://orcid.org/0000-0002-1733-5072View further author information
ORCID Icon,
Jaafar Bennouna6 University Hospital of Nantes, Nantes, FranceView further author information
,
Toshihiko Doi7 National Cancer Center Hospital East, Kashiwa, JapanView further author information
,
Natalyn Nicole Hawk8 Eisai Inc., Nutley, NJ, USAView further author information
,
Li Yu9 Merck & Co., Inc., Rahway, NJ, USAView further author information
,
Sukrut Shah9 Merck & Co., Inc., Rahway, NJ, USAView further author information
,
Pooja Bhagia9 Merck & Co., Inc., Rahway, NJ, USAView further author information
&
Lin Shen10 Peking University Cancer Hospital & Institute, Beijing, ChinaView further author information
 show all
Received 16 Nov 2022, Accepted 26 Mar 2024, Published online: 02 May 2024

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.